Belite Bio (BLTE) Enterprise Value (2021 - 2025)

Belite Bio's Enterprise Value history runs 5 years deep, the most recent figure standing at -$476.8 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 239.1% year-over-year to -$476.8 million; the TTM figure through Dec 2025 stood at -$476.8 million (down 239.1% YoY), while the FY2025 annual figure was -$476.8 million, down 239.1% from the prior year.
• Enterprise Value was -$476.8 million for Q4 2025 at Belite Bio, down from -$31.7 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$17.3 million in Q4 2021 to a low of -$476.8 million in Q4 2025.
• Historically, Enterprise Value has averaged -$126.4 million across 5 years, with a median of -$88.2 million in 2023.
• Biggest YoY gain for Enterprise Value was 64.07% in 2025; the steepest drop was 239.1% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$17.3 million in 2021, then slumped by 142.67% to -$42.1 million in 2022, then tumbled by 109.45% to -$88.2 million in 2023, then sank by 59.49% to -$140.6 million in 2024, then slumped by 239.1% to -$476.8 million in 2025.
• The last three Enterprise Value figures came in at -$476.8 million (Q4 2025), -$31.7 million (Q3 2025), and -$140.6 million (Q4 2024), per Business Quant data.